FendX Technologies Inc. Announces Entry into Investor Relations Agreement

Oakville, Ontario–(Newsfile Corp. – March 22, 2023) – FendX Technologies Inc. (CSE: FNDX) (the Company” or “FendX“), a nanotechnology company developing surface protection coatings, announces that it has entered into an investor relations agreement (the “Agreement“) with Triomphe Holdings Ltd. (DBA Capital Analytica) (“Capital Analytica“).

Pursuant to the Agreement, Capital Analytica has agreed to provide investor relations and communications services to the Company in exchange for an aggregate amount of $120,000, payable in two equal installments, of which $60,000 has been paid and $60,000 is payable. The services will include on-going social media consultation regarding engagement and enhancement, social sentiment reporting, social engagement reporting, discussion forum monitoring and reporting, corporate video dissemination and other related investor relations services. The term of the Capital Analytica agreement is for a period of six months. Capital Analytica’s contact information is as follows: Jeff French, email: jeff@capitalanalytica.com, telephone: (778) 882-4551.

About FendX Technologies Inc.

FendX is a Canada-based nanotechnology company focused on developing products to make people’s lives safer by reducing the spread of pathogens. Our first product under development, REPELWRAP™ film, is a protective surface coating film that, due to its repelling properties, prevents adhesion of pathogens and reduces their transmission on surfaces prone to contamination. The Company is conducting research and development activities using its nanotechnology in collaboration with industry-leading partners including McMaster University. The Company has an exclusive world-wide license to its technology, including an IP portfolio, from McMaster.

ON BEHALF OF THE BOARD

Carolyn Myers
Carolyn Myers
Chief Executive Officer and Director

For further information, please contact:
Carolyn Myers
Telephone: 1-800-344-9868

For Media and Investor Relations Inquiries:
investor@fendxtech.com

For more information please visit https://fendxtech.com/ and the Company’s profile on SEDAR at www.sedar.com.

Neither the Canadian Securities Exchange nor the Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains certain forward-looking statements within the meaning of Canadian securities legislation, including with respect to: the plans of the Company; and products under development and any pathogen reduction benefits related thereto. Although the Company believes that such statements are reasonable, it can give no assurance that such expectations will prove to be correct. Forward-looking statements are statements that are not historical facts; they are generally, but not always, identified by the words “expects,” “plans,” “anticipates,” “believes,” “intends,” “estimates,” “projects,” “aims,” “potential,” “goal,” “objective,” “prospective,” and similar expressions, or that events or conditions “will,” “would,” “may,” “can,” “could” or “should” occur, or are those statements, which, by their nature, refer to future events. The Company cautions that forward-looking statements are based on the beliefs, estimates and opinions of the Company’s management on the date the statements are made and they involve a number of risks and uncertainties. Consequently, there can be no assurances that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements.

Important factors that could cause future results to differ materially from those anticipated in these forward-looking statements include: product candidates only being in formulation/reformulation stages; limited operating history; research and development activities; dependence on collaborative partners, licensors and others; effect of general economic and political conditions; and other risk factors set forth in the Company’s final prospectus dated January 31, 2023 under the heading “Risk Factors”. The reader is urged to refer to the Company’s prospectus and other filings, publicly available through SEDAR at www.sedar.com for a more complete discussion of such risk factors and their potential effects. Except to the extent required by applicable securities laws and the policies of the Canadian Securities Exchange, the Company undertakes no obligation to update these forward-looking statements if management’s beliefs, estimates or opinions, or other factors, should change.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/159392

FendX Announces LOI with Sinelabs LLC to Pursue Sales and Distribution Agreement for FendX’s Future Surface Protection Products

FendX Announces Grant of Japanese Patent to Protect REPELWRAP(TM) Film

FendX To Present at the Global Markets Forum in New York City and Provides Corporate Update